TWST Twist Bioscience Corporation

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company was founded in 2013 and is headquartered in San Francisco, California.

$27.86  +0.51 (1.87%)
As of 12/01/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  10/31/2018
Outstanding shares:  56,568,420
Average volume:  1,763,326
Market cap:   $1,547,146,287
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BGKG6G7
Valuation   (See tab for details)
PE ratio:   -8.40
PB ratio:   1.81
PS ratio:   9.49
Return on equity:   -21.72%
Net income %:   -114.96%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy